Corcept Therapeutics (CORT) EV to EBITDA (2016 - 2026)
Corcept Therapeutics' (CORT) EV to EBITDA came in at 108.19 for Q3 2026, down 12.5% from 123.70 a year earlier and down 90.4% from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) EV to EBITDA (2016 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EV to EBITDA at Corcept Therapeutics was 99.19, down 8.3% year-over-year; for FY2025, it was 72.16, up 102.3% from FY2024.
- Annual EV to EBITDA has increased for four consecutive years.
- In prior years, Corcept Therapeutics' EV to EBITDA was 35.67 in FY2024 (+29.8%), 27.49 in FY2023 (+78.8%), 15.38 in FY2022 (+3.3%) and 14.88 in FY2021 (-26.7%).
- Quarterly EV to EBITDA has run from a low of 14.93 in Q4 2021 to a high of 1124.56 in Q2 2026 over five years.
- On a year-over-year basis, EV to EBITDA increased in five of the last six quarters, with growth averaging 186.3%.
- The strongest year-over-year quarter for EV to EBITDA in the past five years was Q1 2025, with growth of 485.2%; the weakest was Q1 2022, with a decline of 28.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Corcept Therapeutics | 7.99 Bn | 6.60 Bn | 335.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 108.19 |
| Jun 30, 2026 | 1,124.56 |
| Dec 31, 2025 | 72.16 |
| Sep 30, 2025 | 124.72 |
| Jun 30, 2025 | 71.43 |
| Mar 31, 2025 | 105.26 |
| Dec 31, 2024 | 35.66 |
| Sep 30, 2024 | 31.00 |
| Jun 30, 2024 | 22.71 |
| Mar 31, 2024 | 17.99 |
| Dec 31, 2023 | 27.58 |
| Sep 30, 2023 | 24.61 |
| Jun 30, 2023 | 19.10 |
| Mar 31, 2023 | 17.01 |
| Dec 31, 2022 | 15.44 |
| Sep 30, 2022 | 18.51 |
| Jun 30, 2022 | 16.73 |
| Mar 31, 2022 | 15.43 |
| Dec 31, 2021 | 14.93 |
| Sep 30, 2021 | 16.03 |
API Access
Corcept Therapeutics EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();